BS

Biostem Technologies IncOOTC BSEM Stock Report

Last reporting period 30 Sep, 2023

Updated 13 Nov, 2024

Last price

Market cap $B

0.009

Micro

Exchange

OOTC - OTC

BSEM Stock Analysis

BS

Uncovered

Biostem Technologies Inc is uncovered by Eyestock quantitative analysis.

Market cap $B

0.009

Dividend yield

Shares outstanding

8.531 B

BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. The company is headquartered in Pompano Beach, Florida. The company went IPO on 2001-07-11. The firm is focused on manufacturing products through its BioRetain processing method. BioRetain has been developed by applying the research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. The Company’s portfolio of brands includes VENDAJE, VENDAJE AC and VENDAJE OPTIC. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE AC is a structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds.

View Section: Eyestock Rating